Pandameds.Com Editorial Team
The Pandameds.Com Editorial Team is dedicated to delivering accurate, transparent and trustworthy health information to help U.S. customers access safe, affordable weight loss medications from Canada. Our team of experienced medical writers, pharmacists and industry professionals ensures every article and product page is thoroughly fact checked, clearly written & updated to reflect the latest clinical guidance.
Each piece of content undergoes a stringent editorial process referencing trusted medical sources such as FDA, Health Canada, PubMed and Mayo Clinic. While we do not provide individual medical advice, our mission is to empower readers with reliable knowledge about medications like Ozempic, Saxenda, Mounjaro, Zepbound, Wegovy and Rybelsus, focused exclusively on their role in medical weight management.
Pandameds.Com helps our readers make informed decisions about their health maintaining a transparent editorial policy and working with certified reviewers
Recent Blog Post
Saxenda vs Mounjaro: Mounjaro 22.5% Loss vs Saxenda 8% – Head-to-Head Analysis
Mounjaro dominates Saxenda across every major metric: 22.5% body weight loss vs 8%, once-weekly injection vs daily injection, and dual GLP-1/GIP mechanism vs single GLP-1. Both Saxenda and Mounjaro are prescription medications designed to support weight management by reducing appetite and helping patients lose weight when combined with lifestyle changes. However, clinical trial data shows [...]
Rybelsus vs Januvia: Oral GLP-1 vs DPP4 Comparison (Weight Loss, A1C, Cost)
Rybelsus and Januvia are two widely prescribed oral medications for adults with type 2 diabetes, but they belong to fundamentally different drug classes. Rybelsus (oral semaglutide), manufactured by Novo Nordisk, is a GLP-1 receptor agonist the first of its kind available as an oral tablet rather than an injection. Januvia (sitagliptin), produced by Merck, is [...]
Trulicity Cost: $987 Monthly Without Insurance + Savings Guide
Trulicity is a brand-name GLP-1 receptor agonist manufactured by Eli Lilly and prescribed primarily for managing type 2 diabetes. Because no generic version exists, out-of-pocket expenses can be steep. The cost of Trulicity depends on a few factors: your insurance plan, dosage, pharmacy location, and whether you qualify for manufacturer savings programs or patient assistance [...]
Rybelsus vs Metformin: Oral GLP-1 vs Biguanide Comparison (Weight Loss, A1C, Cost)
Rybelsus and metformin are both prescription medications used to lower blood sugar levels in adults with type 2 diabetes, but these two diabetes medications work differently and belong to separate drug classes. Rybelsus is a brand-name oral GLP-1 receptor agonist containing the active ingredient semaglutide. It works by mimicking the hormone GLP-1 to increase insulin [...]
Farxiga vs Ozempic: SGLT2 vs GLP-1 Comparison (Weight Loss, A1C, Cost)
Dapagliflozin (Farxiga) and semaglutide (Ozempic) are both medications used to treat type 2 diabetes, yet they work through entirely different pharmacological pathways. Farxiga is an SGLT2 inhibitor an oral medication that lowers blood glucose levels by blocking glucose reabsorption in the kidneys, causing sugar to be eliminated through urine. Ozempic is a GLP-1 receptor agonist [...]
Saxenda Cost 2026: $1,349 Monthly Without Insurance + $25 Savings Guide
The list price for Saxenda (liraglutide) is $1,349.02 for a 30-day supply, which includes five 3mL prefilled injectable pens. Saxenda is an FDA-approved GLP-1 receptor agonist prescription medication designed to help adults with obesity or overweight with weight-related medical conditions lose weight and maintain weight loss when used with a reduced calorie diet and increased [...]
Zepbound Cost: $1,086 Monthly List + $25 Copay Savings Guide
According to Lilly's official pricing information, the list price of Zepbound is $1,086 per month for a 28-day supply (4 pre-filled pens). This applies to all dosage strengths from 2.5 mg to 15 mg. However, your actual monthly costs depend on insurance coverage, discount eligibility, and how you access care. The medication is administered as [...]
Metformin vs Ozempic: Weight Loss + Combination Therapy
Metformin has been a cornerstone of type 2 diabetes treatment for over five decades, recommended by the American Diabetes Association as a first-line treatment alongside lifestyle changes. Ozempic (semaglutide), approved by the FDA in 2017, represents the newer class of GLP-1 receptor agonists that have transformed diabetes care and weight management. The key differences between [...]
Does Ozempic Lower Blood Sugar & Pressure?
Ozempic (semaglutide) is an injectable GLP-1 receptor agonist that the Food and Drug Administration (FDA) approved to improve blood sugar levels in adults with type 2 diabetes. Beyond blood sugar management, research suggests that Ozempic also lowers blood pressure. A 2023 systematic review and meta-analysis published in the Journal of Clinical Medicine found that semaglutide [...]
Tirzepatide vs Semaglutide: Dual GIP/GLP-1 vs GLP-1 (Weight Loss, A1C, Cost)
Tirzepatide outperforms semaglutide for weight loss and blood sugar control in most clinical settings. In the landmark SURPASS-2 trial published in the New England Journal of Medicine, tirzepatide at its highest dose (15 mg) achieved roughly double the weight reduction of semaglutide 1 mg at 40 weeks. For chronic weight management in adults with obesity, [...]
